3A Research | El Paso, TX - East Location

Research site

(Unclaimed)

Location

10400 Vista Del Sol Suite 104, El Paso, Texas, United States of America

Site insights

Top conditions

Top treatments

Adapalene

SCD-044

Rifaximin

Tenapanor

Ritlecitinib

Differin

DFD-29

Parent organization

This site is a part of 3A Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess th...

Enrolling

Chronic Idiopathic Constipation (CIC)

Drug: Tenapanor 50 mg BID

Drug: Tenapanor 5 mg BID

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. (B7981028)

The purpose of this clinical trial is to learn about long-term safety and long-term effects of the study medicine (called ritlecitinib) for the poten...

Enrolling

Severe Alopecia Areata

Drug: Ritlecitinib lower dose

Drug: Ritlecitinib higher dose